CCA
ABMD

Checchi Capital Advisers’s Abiomed Inc ABMD Stock Holding History

Checchi Capital Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-493
Closed -$222K – 455
2018
Q3 		$222K Buy
+493
New +$194K 0.03% 385
2016
Q3 		– Sell
-54
Closed -$6K – 1309
2016
Q2 		$6K Hold
54
– – ﹤0.01% 1378
2016
Q1 		$5K Buy
+54
New +$4.56K ﹤0.01% 1420

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Checchi Capital Advisers's ABMD Position: Q4 2018 in Review

Checchi Capital Advisers sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 493 shares — an estimated $222K sold.

Checchi Capital Advisers first reported a position in ABMD in Q1 2016 and held it in 3 quarters. The position peaked at $222K in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Checchi Capital Advisers reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Checchi Capital Advisers sold 493 Abiomed Inc shares in Q4 2018, an estimated $222K.
  • Checchi Capital Advisers first reported a position in Abiomed Inc in Q1 2016 and held it in 3 quarters.
  • Checchi Capital Advisers's Abiomed Inc position peaked at $222K in Q3 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Checchi Capital Advisers's 13F filing for Q4 2018, filed 7 Feb 2019.